Medical Innovation Act of 2024
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Medical Innovation Act of 2024 is a Senate bill introduced in the 118th Congress aimed at advancing medical innovation. The bill was read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions but ultimately failed or expired without further action. No official summary or full text is available, limiting detailed analysis of its provisions. The bill falls under the health policy area and was intended to address issues related to medical research, development, or innovation.
The Medical Innovation Act of 2024 sought to promote medical innovation but did not progress beyond committee referral and expired without enactment.
- Introduced in the Senate during the 118th Congress as S.5339.
- Referred to the Committee on Health, Education, Labor, and Pensions after being read twice.
- The bill did not advance and is listed as failed or expired as of December 5, 2025.
['Medical researchers and innovators', 'Healthcare industry stakeholders', 'Patients potentially benefiting from medical advancements', 'Federal agencies involved in health and medical research']
['Lack of publicly available bill text and summary limits transparency and understanding of specific provisions.', 'Unclear funding mechanisms or authority granted due to missing full text.', 'Potential oversight and implementation challenges cannot be assessed without detailed content.']
The bill was introduced in the Senate and referred to a relevant committee but did not proceed to further legislative stages. Its failure or expiration indicates it did not gain sufficient traction or priority during the 118th Congress. The health policy area often involves complex stakeholder interests and regulatory considerations.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
["Potential delays or missed opportunities in medical innovation due to the bill's failure to advance.", 'Continued reliance on existing frameworks for medical research and innovation without new legislative support.']
The absence of an official summary and full bill text restricts comprehensive analysis and public scrutiny. Transparency in legislative documentation is critical for informed debate and oversight. The bill's failure to progress highlights the importance of accessible information for tracking legislative priorities and impacts.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.